These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 8485633)

  • 1. The role of corticotropin-releasing factor and noradrenaline in stress-related responses, and the inter-relationships between the two systems.
    Dunn AJ; Swiergiel AH
    Eur J Pharmacol; 2008 Apr; 583(2-3):186-93. PubMed ID: 18281033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corticotropin-releasing factor: effect on cerebral blood flow in physiologic and ischaemic conditions.
    De Michele M; Touzani O; Foster AC; Fieschi C; Sette G; McCulloch J
    Exp Brain Res; 2005 Sep; 165(3):375-82. PubMed ID: 15864562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRF2 receptors are highly expressed in the human cardiovascular system and their cognate ligands urocortins 2 and 3 are potent vasodilators.
    Wiley KE; Davenport AP
    Br J Pharmacol; 2004 Oct; 143(4):508-14. PubMed ID: 15381637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of a cutaneous corticotropin-releasing hormone system.
    Slominski A; Pisarchik A; Tobin DJ; Mazurkiewicz JE; Wortsman J
    Endocrinology; 2004 Feb; 145(2):941-50. PubMed ID: 14605004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Placental stress factors and maternal-fetal adaptive response: the corticotropin-releasing factor family.
    Florio P; Severi FM; Ciarmela P; Fiore G; Calonaci G; Merola A; De Felice C; Palumbo M; Petraglia F
    Endocrine; 2002 Oct; 19(1):91-102. PubMed ID: 12583606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corticotropin-releasing factor receptor 2 is a tonic suppressor of vascularization.
    Bale TL; Giordano FJ; Hickey RP; Huang Y; Nath AK; Peterson KL; Vale WW; Lee KF
    Proc Natl Acad Sci U S A; 2002 May; 99(11):7734-9. PubMed ID: 12032352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urocortin-induced endothelium-dependent relaxation of rat coronary artery: role of nitric oxide and K+ channels.
    Huang Y; Chan FL; Lau CW; Tsang SY; He GW; Chen ZY; Yao X
    Br J Pharmacol; 2002 Mar; 135(6):1467-76. PubMed ID: 11906960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urocortin relaxes rat tail arteries by a PKA-mediated reduction of the sensitivity of the contractile apparatus for calcium.
    Lubomirov L; Gagov H; Petkova-Kirova P; Duridanova D; Kalentchuk VU; Schubert R
    Br J Pharmacol; 2001 Dec; 134(7):1564-70. PubMed ID: 11724764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies of the role of endothelium-dependent nitric oxide release in the sustained vasodilator effects of corticotrophin releasing factor and sauvagine.
    Barker DM; Corder R
    Br J Pharmacol; 1999 Jan; 126(1):317-25. PubMed ID: 10051151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the effect of dopamine in primate arteries and veins.
    Okamura T; Toda N
    Hypertens Res; 1995 Jun; 18 Suppl 1():S35-7. PubMed ID: 8529071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral anti-inflammatory actions of corticotropin-releasing factor.
    Wei ET; Gao GC; Thomas HA
    Ciba Found Symp; 1993; 172():258-68; discussion 268-76. PubMed ID: 7683982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relaxing actions of corticotropin-releasing factor on rat resistance arteries.
    Lei S; Richter R; Bienert M; Mulvany MJ
    Br J Pharmacol; 1993 Apr; 108(4):941-7. PubMed ID: 8485633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelium-dependent and -independent mechanisms of vasorelaxation by corticotropin-releasing factor in pregnant rat uterine artery.
    Jain V; Vedernikov YP; Saade GR; Chwalisz K; Garfield RE
    J Pharmacol Exp Ther; 1999 Feb; 288(2):407-13. PubMed ID: 9918539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the relaxant action of urocortin, a new peptide related to corticotropin-releasing factor in the rat isolated basilar artery.
    Schilling L; Kanzler C; Schmiedek P; Ehrenreich H
    Br J Pharmacol; 1998 Nov; 125(6):1164-71. PubMed ID: 9863643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of action of cicletanine in human and guinea pig resistance arteries.
    Calder JA; Schachter M; Sever PS
    J Cardiovasc Pharmacol; 1992 Mar; 19(3):387-93. PubMed ID: 1378119
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.